Search
for
Sort by
Research 421–450 of 726
- From Diospyros kaki L. (Persimmon) Phytochemical Profile and Health Impact to New Product Perspectives and Waste Valorization
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Multisystemic eosinophilic epitheliotropic disease in a horse in Brazil
- The role of glucose metabolism in wound healing: an overview
- A New Horizon in Facial Plastic Surgery: Skin Tissue-Engineering and Stem Cell Therapy—Reality or Dream?
- Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Proteomic Analysis of Two Stem Cell Secretomes Used in Combination in a Topical Skin Care Product That Has Demonstrated Efficacy in a Double-Blinded, Vehicle-Controlled Clinical Trial
- ZINC AND HUMAN HEALTH: IMPLICATIONS OF ZINC DEFICIENCY IN IMMUNE, GASTROINTESTINAL, DERMATOLOGICAL, AND METABOLIC DISORDERS
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- 85 Primary cutaneous follicle center lymphoma spans yet unrecognised subtypes including polyclonal reactions
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Ectopic olfactory receptors in human: New therapeutic possibilities
- Wound repair at a glance
- Unraveling the web of defense: the crucial role of polysaccharides in immunity
- Combined Systemic and Cutaneous Ovalbumin–Aluminum Sensitization Triggers Thermal Hyperalgesia, Spinal Gliosis, and Nociceptive Nerve Fibers Sprouting in Mice
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Emerging roles of transit‐amplifying cells in tissue regeneration and cancer
- The role of WNT10B in physiology and disease: A 10-year update